The recently published ADAPTABLE study seeks to answer, definitively, a long held question: What is the correct dose of aspirin to improve outcomes in secondary prevention of cardiovascular disease? Also, more information about PCORnet, which is referenced in the article and during the episode, may be found here: https://pcornet.org/

Redeem your CPE or CME credit here!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964

References and resources:
Jones WS, Mulder H, Wruck LM, et al. Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2102137. Epub ahead of print. PMID: 33999548.

Continuing Education Information:
Learning Objectives:
1. Describe the outcomes and design of the ADAPTABLE study
2. Discuss some of the limitations of this trial in its application to specific patients

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-229-H01-P
0.50 AMA PRA Category 1 Credits™
Initial release date: 7/6/21
Expiration date: 7/6/22
Complete CPE & CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram